308 related articles for article (PubMed ID: 7202494)
21. The [3H]5-HT and [3H]spiroperidol binding sites in the rat frontal cortex and thermally inactivated at different rates.
Poller D; Carroll JA; Middlemiss DN
Eur J Pharmacol; 1981 Jun; 72(1):121-3. PubMed ID: 7262190
[No Abstract] [Full Text] [Related]
22. Multiple receptors for serotonin in the rat brain.
Hamon M; Nelson DL; Herbet A; Glowinski J
Adv Biochem Psychopharmacol; 1980; 21():223-33. PubMed ID: 7376970
[No Abstract] [Full Text] [Related]
23. Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat.
Agnati LF; Benfenati F; Battistini N; Cavicchioli L; Fuxe K; Toffano G
Acta Physiol Scand; 1983 Feb; 117(2):311-4. PubMed ID: 6869038
[No Abstract] [Full Text] [Related]
24. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
25. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
[TBL] [Abstract][Full Text] [Related]
26. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain.
Usdin TB; Creese I; Snyder SH
J Neurochem; 1980 Mar; 34(3):669-76. PubMed ID: 6766497
[No Abstract] [Full Text] [Related]
27. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
[TBL] [Abstract][Full Text] [Related]
28. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
Hruska RE
J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
[TBL] [Abstract][Full Text] [Related]
29. Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat.
Agnati LF; Fuxe K; Benfenati F; Celani MF; Battistini N; Mutt V; Cavicchioli L; Galli G; Hökfelt T
Neurosci Lett; 1983 Feb; 35(2):179-83. PubMed ID: 6304577
[No Abstract] [Full Text] [Related]
30. Inhibition of [3H]spiperone binding to 5-HT2 receptors of rat cerebral cortex by the calcium antagonists verapamil and D600.
Taylor JE; Defeudis FV
Eur J Pharmacol; 1984 Oct; 106(1):215-6. PubMed ID: 6529970
[No Abstract] [Full Text] [Related]
31. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
Tachizawa H; Sudo K; Sano M
Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
[TBL] [Abstract][Full Text] [Related]
32. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
Köhler C; Ogren SO; Haglund L; Angeby T
Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
[TBL] [Abstract][Full Text] [Related]
33. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
Cross AJ; Waddington JL
Eur J Pharmacol; 1981 May; 71(2-3):327-32. PubMed ID: 7250192
[TBL] [Abstract][Full Text] [Related]
34. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
[No Abstract] [Full Text] [Related]
35. (3H) spiroperidol binding decreases in brains of rats infected with Venezuelan equine encephalomyelitis virus.
Bonilla E; Salazar M; Estevez J; Hernández H; Rangel P
Experientia; 1984 Aug; 40(8):868-9. PubMed ID: 6468605
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
Neve KA; Altar CA; Wong CA; Marshall JF
Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
[TBL] [Abstract][Full Text] [Related]
37. Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release.
Nielsen EB; Nielsen M; Braestrup C
Psychopharmacology (Berl); 1983; 81(1):81-5. PubMed ID: 6415736
[TBL] [Abstract][Full Text] [Related]
38. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
[TBL] [Abstract][Full Text] [Related]
39. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
40. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
Leslie CA; Bennett JP
Brain Res; 1987 Mar; 407(2):253-62. PubMed ID: 2952221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
